Envestnet Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.8M Buy
428,564
+16,128
+4% +$3.17M 0.02% 607
2026
Q1
$80.8M Buy
412,436
+78,633
+24% +$15.3M 0.02% 604
2025
Q4
$57.9M Sell
333,803
-44,368
-12% -$8.08M 0.02% 676
2025
Q3
$72.1M Sell
378,171
-15,848
-4% -$2.81M 0.02% 620
2025
Q2
$70.8M Buy
394,019
+47,382
+14% +$8.23M 0.02% 620
2025
Q1
$58.7M Buy
346,637
+63,314
+22% +$10.4M 0.02% 650
2024
Q4
$42.7M Buy
283,323
+27,339
+11% +$4.25M 0.01% 792
2024
Q3
$39.7M Buy
255,984
+29,386
+13% +$4.39M 0.01% 827
2024
Q2
$31M Buy
226,598
+6,230
+3% +$853K 0.01% 882
2024
Q1
$29.3M Buy
220,368
+60,226
+38% +$7.81M 0.01% 904
2023
Q4
$22.1M Sell
160,142
-3,463
-2% -$455K 0.01% 977
2023
Q3
$19.9M Sell
163,605
-36,407
-18% -$4.85M 0.01% 973
2023
Q2
$28.1M Sell
200,012
-34,051
-15% -$4.69M 0.01% 758
2023
Q1
$33.1M Sell
234,063
-11,100
-5% -$1.59M 0.02% 640
2022
Q4
$38.4M Buy
245,163
+9,313
+4% +$1.34M 0.02% 557
2022
Q3
$28.9M Buy
235,850
+1,211
+0.5% +$159K 0.02% 611
2022
Q2
$31.2M Buy
234,639
+42,550
+22% +$5.8M 0.02% 592
2022
Q1
$26.3M Buy
192,089
+12,330
+7% +$1.72M 0.01% 723
2021
Q4
$31.1M Buy
179,759
+28,014
+18% +$4.26M 0.02% 661
2021
Q3
$22.1M Buy
151,745
+6,680
+5% +$977K 0.01% 761
2021
Q2
$19.1M Sell
145,065
-40,915
-22% -$5.36M 0.01% 806
2021
Q1
$23.9M Buy
185,980
+31,916
+21% +$3.93M 0.02% 656
2020
Q4
$18.4M Sell
154,064
-72,677
-32% -$8.86M 0.01% 651
2020
Q3
$26M Buy
226,741
+6,753
+3% +$798K 0.02% 469
2020
Q2
$25.1M Sell
219,988
-110,276
-33% -$11.7M 0.02% 459
2020
Q1
$26.5M Buy
330,264
+81,876
+33% +$8.48M 0.03% 373
2019
Q4
$26.5M Buy
248,388
+51,136
+26% +$5.33M 0.03% 435
2019
Q3
$21.1M Buy
197,252
+83,807
+74% +$8.6M 0.02% 472
2019
Q2
$11.6M Buy
113,445
+25,796
+29% +$2.48M 0.01% 665
2019
Q1
$7.88M Buy
87,649
+40,499
+86% +$3.51M 0.01% 789
2018
Q4
$3.93M Buy
+47,150
New +$4.42M 0.01% 1004
2018
Q3
Sell
-8,120
Closed -$892K 1572
2018
Q2
$892K Buy
8,120
+4,417
+119% +$460K ﹤0.01% 1097
2018
Q1
$372K Sell
3,703
-4,422
-54% -$453K ﹤0.01% 1323
2017
Q4
$799K Buy
8,125
+60
+0.7% +$5.69K ﹤0.01% 1300
2017
Q3
$755K Sell
8,065
-372
-4% -$39.5K ﹤0.01% 1267
2017
Q2
$939K Sell
8,437
-2,944
-26% -$311K ﹤0.01% 1217
2017
Q1
$1.12M Sell
11,381
-5,261
-32% -$502K ﹤0.01% 1176
2016
Q4
$1.53M Buy
16,642
+1,555
+10% +$134K 0.01% 1032
2016
Q3
$1.28M Sell
15,087
-86,847
-85% -$7.29M ﹤0.01% 1136
2016
Q2
$8.3M Sell
101,934
-14,358
-12% -$1.09M 0.03% 447
2016
Q1
$8.31M Sell
116,292
-15,562
-12% -$1.04M 0.04% 412
2015
Q4
$9.38M Sell
131,854
-8,274
-6% -$556K 0.04% 363
2015
Q3
$8.61M Buy
140,128
+509
+0.4% +$35.6K 0.04% 361
2015
Q2
$10.1M Sell
139,619
-16,017
-10% -$1.18M 0.05% 371
2015
Q1
$12M Buy
155,636
+154,333
+11,844% +$11.1M 0.06% 303
2014
Q4
$87K Sell
1,303
-267
-17% -$16.8K ﹤0.01% 1221
2014
Q3
$95K Buy
1,570
+1,098
+233% +$67.7K ﹤0.01% 1307
2014
Q2
$28K Buy
472
+323
+217% +$18.9K ﹤0.01% 1645
2014
Q1
$9K Buy
149
+112
+303% +$6K ﹤0.01% 1913
2013
Q4
$2K Sell
37
-1,348
-97% -$80K ﹤0.01% 2225
2013
Q3
$86K Buy
1,385
+283
+26% +$16.9K ﹤0.01% 1021
2013
Q2
$67K Buy
+1,102
New +$65.7K ﹤0.01% 1104

Other funds holding DGX

Envestnet Asset Management's DGX Position: Q2 2026 in Review

Envestnet Asset Management increased its Quest Diagnostics (DGX) stake by 3.9% in Q2 2026, buying an estimated $3.17M and bringing the position to 428,564 shares worth $90.8M. The position accounts for 0.02% of the portfolio, ranked #607.

Envestnet Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Envestnet Asset Management held 428,564 shares of Quest Diagnostics worth $90.8M as of Q2 2026.
  • Envestnet Asset Management bought 16,128 Quest Diagnostics shares in Q2 2026, an estimated $3.17M.
  • Quest Diagnostics made up 0.02% of Envestnet Asset Management's portfolio in Q2 2026, its #607 holding.
  • Envestnet Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.